Greater Philly’s largest health insurer to restrict coverage for weight loss medications, citing ‘exorbitant costs’

Your browser doesn’t support HTML5 audio

FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 – and as young as 12. (AP Photo/David J. Phillip, File)

Share

Recent Posts